Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits

Infection and Immunity

Volumn 69, Issue 2, 2001, Pages 1101-1108

  Ogawa, M ^a   Shimizu, K ^a   Nomoto, K ^a   Takahashi, M ^a   Watanuki, M ^a   Tanaka, R ^a   Tanaka, T ^a   Hamabata, T ^a   Yamasaki, S ^a   Takeda, Y ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN A; LACTIC ACID; PROBIOTIC AGENT; SHIGA TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; ESCHERICHIA COLI; GASTROINTESTINAL INFECTION; IMMUNE RESPONSE; INTESTINE MUCOSA; LACTOBACILLUS CASEI; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RABBIT;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, BACTERIAL; DIGESTIVE SYSTEM; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; HYDROGEN-ION CONCENTRATION; LACTIC ACID; LACTOBACILLUS CASEI; RABBITS; SHIGA TOXIN;

EID: 0035140141     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.2.1101-1108.2001     Document Type: Article

References (67)

1. Hand-rearing of rabbits using rabbit milk and commercial milk powder
2. In vitro studies on the growth of Shigella sonnei by Lactobacillus casei and Lact. acidophilus
3. Beneficial effects of administration of Lactobacillus acidophilus in diarrhoeal and other intestinal disorders
4. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers
5. Colonization of chicken cecae by Escherichia coli associated with hemorrhaghic colitis
6. The influence of pH, temperature and organic acids on the initiation of growth of Yersinia enterocolitica
7. The neurotoxin of Shigella shigae: A comparative study of the effects produced in various laboratory animals
8. Long-term prophylaxis of infection by selective decontamination in leukopenia and in mechanical ventilation
9. NMR studies of pH-induced transport of carboxylic acids across phospholipid vesicle membranes
10. The antimicrobial effect of dissociated and undissociated sorbic acid at different pH levels
11. Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man
12. Fate of pathogenic and non-pathogenic Escherichia coli strains in two fermented milk products
13. Evaluation of antiinfective activity of an association Bifidobacterium/Lactobacillus in mouse intestine
14. Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7
15. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice
16. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection
17. Protective effect of Japanese green tea extract on gnotobiotic mice infected with an Escherichia coli O157:H7 strain
18. Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain
19. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain
20. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea
21. The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection
22. Secretory immunoglobulin A response to Shiga toxin in rabbits: Kinetics of the initial mucosal immune response and inhibition of toxicity in vitro and in vivo
23. Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice
24. Role of probiotics in health and diseases
25. Escherichia coli that cause diarrhea: Enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent
26. The effect of enterohemorrhagic Escherichia coli O157:H7 on intestinal structure and solute transport in rabbits
27. Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model
28. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake
29. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis
30. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG
31. Mucosal immune response to RDEC-1 infection: Study of lamina propria antibody-producing cells and biliary antibody
32. Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice
33. Diarrheal disease caused by enterotoxigenic Bacteroides fragilis in infant rabbits
34. Inhibition of Shigella sonnei by Lactobacillus casei and Lact. acidophilus
35. Experimental infection of infant rabbits with verocytotoxin-producing Escherichia coli of bovine origin
36. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin
37. Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei
38. Prevention of indigenous infection of mice with Escherichia coli by nonspecific immunostimulation
39. Mucosal and systemic responses following enteric exposure to lactic acid bacteria
40. Development of a highly sensitive bead-ELISA to detect bacterial protein toxins
41. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2)
42. Experimental infection of infant rabbits with verotoxin-producing Escherichia coli
43. Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli
44. Antibodies to lipopolysaccharide block adherence of Shiga toxin-producing Escherichia coli to human intestinal epithelial (Henle 407) cells
45. Prevention of gastrointestinal infection using immunobiological methods with milk fermented with Lactobacillus casei and Lactobacillus acidophilus
46. Immunoadjuvant activity of oral Lactobacillus casei: Influence of dose on the secretory immune response and protective capacity in intestinal infections
47. Immune system stimulation by probiotics
48. Diarrhea due to Escherichia coli O157:H7 in the infant rabbit
49. Risk of hemolytic uremic syndrome after sporadic Escherichia coli 0157:H7 infection: Results of a Canadian collaborative study
50. Enhancement of host resistance against Listeria infection by Lactobacillus casei: Role of macrophages
51. Enhancement of host resistance against Listeria infection by Lactobacillus casei: Activation of liver macrophages and peritoneal macrophages by Lactobacillus casei
52. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children
53. Role of Shiga-like toxin I in bacterial enteritis: Comparison between isogenic Escherichia coli strains induced in rabbits
54. Synthesis and secretion of local immunoglobulin by the intestinal tract of newborn rabbits
55. Escherichia coli O157:H7: Clinical, diagnostic, and epidemiological aspects of human infection
56. Inhibitory effect of Lactobacillus acidophilus
57. The pathogenesis of hemorrhagic colitis caused by Escherichia coli O157:H7 in gnotobiotic piglets
58. Colonization resistance
59. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7
60. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II
61. Animals as a source of Escherichia coli pathogenic for human beings
62. Experimental infection of specificpathogen-free mice with enterohemorrhagic Escherichia coli O157:H7
63. Typing of verotoxins by DNA colony hybridization with poly- and oligonucleotide probes, a bead-enzyme-linked immunosorbent assay, and polymerase chain reaction
64. Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: Selective isolation from feces and identification using monoclonal antibodies
65. Purification and some properties of a Veto toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin